Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group:: Comparison with the activities of 14 other agents

被引:25
作者
Betriu, C [1 ]
Gómez, M [1 ]
Palau, ML [1 ]
Sánchez, A [1 ]
Picazo, JJ [1 ]
机构
[1] Hosp Clin San Carlos, Serv Microbiol Clin, Madrid 28040, Spain
关键词
D O I
10.1128/AAC.43.9.2320
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the beta-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 mu g/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 mu g/ml, respectively.
引用
收藏
页码:2320 / 2322
页数:3
相关论文
共 20 条
  • [11] Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria
    Edlund, C
    Sabouri, S
    Nord, CE
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (03) : 193 - 195
  • [12] ANTIMICROBIAL RESISTANCE IN ANAEROBIC-BACTERIA - CURRENT SITUATION
    GARCIARODRIGUEZ, JA
    GARCIASANCHEZ, JE
    MUNOZBELLIDO, JL
    [J]. ANAEROBE, 1995, 1 (02) : 69 - 80
  • [13] In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds
    Hoellman, DB
    Spangler, SK
    Jacobs, MR
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 495 - 501
  • [14] Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria
    MacGowan, AP
    Bowker, KE
    Holt, HA
    Wootton, M
    Reeves, DS
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (04) : 503 - 509
  • [15] National Committee for Clinical Laboratory Standards, 1993, NCCLS PUBL
  • [16] SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO THE NEW STREPTOGRAMIN RP-59500 INVITRO
    NORD, CE
    LINDMARK, A
    PERSSON, I
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (12) : 1064 - 1067
  • [17] Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994
    Snydman, DR
    McDermott, L
    Cuchural, GJ
    Hecht, DW
    Iannini, PB
    Harrell, LJ
    Jenkins, SG
    OKeefe, JP
    Pierson, CL
    Rihs, JD
    Yu, VL
    Finegold, SM
    Gorbach, SL
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 : S54 - S65
  • [18] Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species
    Snydman, DR
    McDermott, L
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 : S96 - S100
  • [19] LONGITUDINAL-STUDY OF SUSCEPTIBILITIES OF SPECIES OF THE BACTEROIDES-FRAGILIS GROUP TO 5 ANTIMICROBIAL AGENTS IN 3 MEDICAL-CENTERS
    TURGEON, P
    TURGEON, V
    GOURDEAU, M
    DUBOIS, J
    LAMOTHE, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) : 2276 - 2279
  • [20] In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria
    Wexler, HM
    Molitoris, E
    Molitoris, D
    Finegold, SM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 2232 - 2235